Stejbach Mark
SEC-identified person · CIK 1487937 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Indivior Pharmaceuticals, Inc. INDV | Director | filed 2026–2026 |
| Flexion Therapeutics Inc FLXN | Director | filed 2016–2021 |
| Alkermes plc. ALKS | SVP/Chief Comm Off, Alks Inc | filed 2012–2018 |
| Tengion INC TNGN | VP and Chief Commercial Offcr | filed 2010–2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.